Neurovascular Embolectomy Device Market (Type: Aspiration devices, Stent retrievers) - Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 141

Introduction

Neurovascular embolectomy device is used during an embolectomy procedure. These devices are used for removal of emboli, obstructing the blood circulation, surgically. Usually, embolectomy is the least preferred option for treatment and other involved therapeutic options are anticoagulation and thrombolysis. Neurovascular device market has undergone a demand-shift with respect to products and techniques. Doctors want to adopt instruments and techniques that offer higher window for stroke treatment with high success rate and minimal post-surgical impact. This is supported by the fact that demand for bare platinum coils is growing at a higher pace in comparison to coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum coils. Additionally, stroke treatment involves high healthcare expenditure that drives the focus on development of economical treatment techniques.

Market Dynamics

Neurovascular embolectomy device market is driven by increasing cases of strokes, innovation and product development, international trade, and increasing consumer awareness for strokes across the globe. Globally, the expenditure capacity of consumers has risen. Superior healthcare treatment with better devices that offer improved success rate increase the adoption of neurovascular embolectomy devices. Growing consumer knowledge for post surgery safety has increased the application of apt devices suitable for patients. Hence, rising expenditure capacity and increasing knowledge of consumers are also fuelling the demand of neurovascular embolectomy devices market. Also, elevated incidences of reinstating blood flow along with high success rates of functional independence among patients also support the market growth. Large scale random trails in year 2016-17 deep-rooted the significance of speedily clearing the occlusive clot from brain. Additionally, rising healthcare awareness is fuelling the growth of global clot neurovascular embolectomy devices market. Conversely, scarcity of skilled doctors and insufficient reimbursements in developing nations are key factors restraining the growth of the market. Furthermore, there are stringent compliances that device manufacturers & user facilities have to adhere to. These compliances must be reported as per the FDA’s user facility reporting requirement. This enables FDA to identify & analyze the risk related with neurovascular embolectomy devices.

Among neurovascular embolectomy device application fragments, stent retrievers held most astounding piece of the overall industry in 2017 as far as income and volume are concerned. Owing to the factors such as unique overlapping stent retriever-based technology, restores blood flow and retrieves clots from occluded blood vessels in the brain for patients experiencing acute ischemic stroke (AIS) due to a large vessel occlusion (LVO). In fact, the Solitaire device is indicated to reduce stroke-related disability by showing nearly 70% relative improvements in functional outcomes at 90 days in patients suffering a large vessel occlusion. North America is the largest market for neurovascular devices. As per Stroke Association, approximately 1 million Americans each year are affected by stroke which is one of the leading triggers of disability and death. Solitarily in the U.S., the financial drain of stroke is valued at around USD 30 billion annually, which includes the expenditure on health care services, prescriptions, and reduced output. The ASA has put up great effort to transform the existing healthcare systems and patients worldwide by collaborating with other countries, governments and international cerebrovascular societies. Europe is the second largest market for neurovascular embolectomy devices. However, the adoption rate of neurovascular embolectomy devices in Europe is less than that of North America. This is owing to the compliances laid down by European Union regulatory authority. Pursued by, China and India which also experiences similar stroke risk factors as western countries.

Report Coverage

Market

Global Neurovascular Embolectomy Device Market

Analysis Period

2013-2025

Base Year

2017

Forecast Data

2018 – 2025

Market Stratification

Product, Geography

Regional Scope

North America, Europe, China, Japan, Southeast Asia, India

Report Coverage

Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

 

The market research study on “Neurovascular Embolectomy Device Market (Product: Aspiration devices, Stent retrievers) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025” offers a detailed insights on the global neurovascular embolectomy device market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global neurovascular embolectomy device market, its product, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global neurovascular embolectomy device market size and volume, and segment markets by product and geography along with the information on companies operating in the market. The neurovascular embolectomy device market analysis is provided for major regional markets including North America, Europe, China, Japan, Southeast Asia, India, followed by major countries. For each region, the market size and volume for different segments has been covered under the scope of report. The players profiled in the report include Medtronic, Boston Scientific Corporation, Teleflex Inc, DePuy Synthes, Cook Medical, Straub Medical AG, LeMaitre Vascular, Inc, Edwards Lifesciences Corporation, iVascular SLU among others.

The global Neurovascular Embolectomy Device market is segmented as below

Market Segmentation

Market By Product

  • Aspiration Systems
  • Stent Retreival Systems

Market By Geography

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Rest of World


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary